Although molecular and mechanistic studies have indicated that numerous regulators engaged in tumor angiogenesis, research on angiogenic inhibitors still focuses on VEGF/VEGFR signaling pathway due to its dominance in the angiogenic system. This evidence concerns the gene KDR and neoplasm.